- Generic name
- Ondansetron
- Strength
- 8 mg
- Dosage form
- Tablet
- Manufactured by
- Edruc Ltd.
Pamista Tablet
About Pamista 8 mg Tablet
Pamista is a tablet containing ondansetron, an anti-emetic medicine. It is used to help prevent nausea and vomiting in certain medical situations. The tablet is available in a strength of 8 mg.
There are 74 brands of Ondansetron listed in Bangladesh. The lowest listed price is Periset 16 mg Suppository at ৳ 1 per unit.
What is Pamista 8 mg Tablet?
Pamista is a tablet form of ondansetron, which belongs to a group of medicines called anti-emetics. It works by blocking a natural substance in the body that can trigger nausea and vomiting. Doctors prescribe it in specific situations, such as when nausea and vomiting are caused by certain cancer treatments, radiotherapy, or after surgery. The tablet is available as an 8 mg strength. Like all medicines, it should be used only when prescribed, and the doctor will decide the right dose and course for each person.
Uses of Pamista
Ondansetron is used to prevent nausea and vomiting that can happen with certain cancer chemotherapy treatments, radiotherapy, and after surgery. It helps control these symptoms so that treatment can be more comfortable. Pamista 8 mg tablets are one way this medicine is given. The doctor will decide if it is suitable and how it should be used. It is not a general treatment for all types of nausea and vomiting.
How to use Pamista
Take Pamista exactly as your doctor tells you. The dose and how long you take it depend on your condition and treatment plan. Swallow the tablet with water, with or without food, unless your doctor says otherwise. Do not change the dose or stop taking it without asking your doctor. If you miss a dose, ask your pharmacist or doctor what to do. Keep the tablets in their original packaging and follow the storage instructions on the label.
Side effects of Pamista
Some people may experience headache, constipation, or diarrhea when taking ondansetron. These are usually mild or moderate. Other side effects have been reported, including a feeling of warmth or flushing, hiccups, and changes in liver enzyme tests. Rarely, serious reactions such as allergic reactions, breathing problems, chest pain, or low potassium levels have occurred. Tell your doctor if you notice any side effect that bothers you or does not go away. Do not try to treat side effects yourself without medical advice.
Safety and precautions
Do not take Pamista if you are allergic to ondansetron or any of its ingredients. It should not be used with apomorphine. Before taking it, tell your doctor if you have liver problems, have had allergic reactions to similar medicines, or have had recent abdominal surgery. It may hide signs of a bowel problem, so your doctor should monitor you. There is limited information about its use in pregnancy and breastfeeding; ask your doctor if you are pregnant, planning to become pregnant, or breastfeeding. Your doctor will decide if it is right for you.
Frequently asked questions
What is Pamista used for and what kind of medicine is it?
Pamista is an anti-emetic medicine. It contains ondansetron and is used to prevent nausea and vomiting caused by certain cancer treatments, radiotherapy, or surgery. It is not for all types of nausea and vomiting. Your doctor will decide if it is suitable for your situation.
Which medicines may interact with Pamista?
Ondansetron is broken down by liver enzymes, so other medicines that affect these enzymes may change how it works in the body. It should not be used with apomorphine. Always tell your doctor or pharmacist about all medicines you take, including those bought without a prescription.
Who should avoid Pamista or ask the doctor first?
Do not take it if you are allergic to ondansetron or any of its ingredients, or if you take apomorphine. Ask your doctor first if you have liver problems, have had recent abdominal surgery, or are pregnant or breastfeeding. Your doctor will check if it is safe for you.
How should I store Pamista tablets?
Store the tablets at a temperature not exceeding 30°C in a dry place. Protect them from light and moisture. Keep all medicines out of the reach of children. Do not use the tablets after the expiry date printed on the pack. Ask your pharmacist if you are unsure about storage.
Indications
- Prevention of nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy.
- Prevention and treatment of post-operative nausea and vomiting.
- Prevention of radiotherapy-induced nausea and vomiting.
Pharmacology
Dosage & Administration
Adults, Pediatric patients (6 months to 18 years):
- 8 mg tablet/orodispersible tablet: Three 0.15 mg/kg doses, up to a maximum of 16 mg per dose.
- 4 mg orodispersible tablet: Three 0.15 mg/kg doses, up to a maximum of 16 mg per dose.
- Injection: Three 0.15 mg/kg doses, up to a maximum of 16 mg per dose, infused intravenously over 15 minutes.
Adults:
- 8 mg tablet/orodispersible tablet: Initial Dose: 8 mg orally 1 to 2 hours before radiotherapy. Post Radiotherapy: 8 mg orally every 8 hours for up to 5 days after a course of treatment.
- 4 mg orodispersible tablet: Three 0.15 mg/kg doses, up to a maximum of 16 mg per dose.
- Injection: Three 0.15 mg/kg doses, up to a maximum of 16 mg per dose, infused intravenously over 15 minutes.
Adults:
- 8 mg tablet/orodispersible tablet: 16 mg given as two 8 mg tablets
- 4 mg orodispersible tablet: 16 mg
- Injection: 4 mg
Pediatrics (40 kg): Injection: 0.1 mg/kg
Chemotherapy-induced Nausea and Vomiting-
Adults/Geriatric/Child of 12 years or over:
- Highly emetogenic cancer chemotherapy: 30 ml (24 mg) Ondansetron Oral Solution administered 30 minutes before start of emetogenic chemotherapy.
- Moderate emetogenic cancer chemotherapy: 10 ml (8 mg) Ondansetron Oral Solution administered 30 minutes before start of emetogenic chemotherapy. A further 10 ml dose should be administered after 8 hours of the first dose. One 10 ml dose should be administered twice a day (every 12 hours) for 1-2 days after completion of chemotherapy.
Oral solution:
Radiotherapy induced Nausea and Vomiting (Adults/Geriatric/Child of 12 years or over):- The recommended oral dosage: 10 ml (8 mg) Ondansetron Oral Solution 3 times daily.
- For total body irradiation: 10 ml (8-mg) Ondansetron Oral Solution should be administered 1 to 2 hours before each fraction of radiotherapy administered each day.
- For single high-dose fraction radiotherapy to the abdomen: one 10 ml Ondansetron Oral Solution should be administered 1 to 2 hours before radiotherapy, with subsequent doses every 8 hours after the first dose for 1 to 2 days after completion of radiotherapy.
- For daily fractionated radiotherapy to the abdomen: 10 ml (8-mg) Ondansetron Oral Solution should be administered 1 to 2 hours before radiotherapy, with subsequent doses every 8 hours after the first dose for each day radiotherapy is given.
- 20 ml (16 mg) Ondansetron Oral Solution 1 hour before induction of anesthesia
Oral Soluble Film:
Prevention of nausea and vomiting associated with highly emetogenic cancer chemotherapy:- Adult oral dose: 24 mg given successively as three 8 mg films 30 minutes before the start of chemotherapy.
- Adults and pediatric patients 12 years of age and older: One 8 mg film 30 minutes before chemotherapy followed by an 8 mg dose 8 hours later. Administer one 8 mg film twice a day (every 12 hours) for 1 to 2 days after completion of chemotherapy.
- Pediatric patients 4 through 11 years of age: One 4 mg film three times a day. Administer the first dose 30 minutes before chemotherapy, with subsequent doses 4 and 8 hours later. Administer one 4 mg film three times a day (every 8 hours) for 1 to 2 days after completion of chemotherapy.
- Prevention of nausea and vomiting associated with radiotherapy: The adult dosage is one 8 mg film three times a day.
- Postoperative nausea and vomiting: The adult dose is 16 mg given successively as two 8 mg films 1 hour before anesthesia.
Interaction
Contraindications
Side Effects
Pregnancy & Lactation
Reproduction studies have been performed in pregnant rats and rabbits at daily oral doses up to 15 and 30 mg/kg per day, respectively, and have revealed no evidence of impaired fertility or harm to the fetus due to Ondansetron. There are, however, no adequate and well-controlled studies in pregnant women. Ondansetron is excreted in the breast milk of rats. So caution should be exercised when Ondansetron is administered to a nursing women.
Precautions & Warnings
Storage Conditions
Alternative brands of Ondansetron
Other brands with the same generic name, cheapest first.
Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.